$34.50
0.07 (+0.20%)
Eli Lilly & Co. (LLY)
CAPS Rating:
The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

RSS Headlines
Fool UK